文献速递间质性肺疾病

端粒短与类风湿关节炎相关间质性肺病加速进展相关

Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease.
PubMed 文献 · Eur Respir J · 2025-12-04

该前瞻性法国观察性研究纳入101例类风湿关节炎相关间质性肺病(RA-ILD)患者,发现43%存在短白细胞端粒长度(LTL)。短LTL组基线用力肺活量(FVC)和弥散功能(D LCO)更低,12个月内功能下降更显著,且12个月内疾病进展更常见,但无移植生存率无差异。

要点

  • 短LTL与RA-ILD基线肺功能更差及12个月内功能加速下降相关。
  • 短LTL组12个月内疾病进展比例更高(47% vs 22%,单因素p=0.011)。
  • 多因素分析中短LTL对12个月进展的OR为2.80(95%CI 0.99-8.29),未达统计学显著。

核心结论

  • 短LTL与RA-ILD基线疾病严重程度及12个月内疾病进展相关。

研究设计与样本

  • 前瞻性法国观察性研究,纳入101例经多学科评估诊断的RA-ILD患者。
  • 入组时采用qPCR测量LTL,短LTL定义为年龄校正后LTL低于第10百分位。

主要发现

  • 短LTL组基线FVC%预计值为82% vs 93%,D LCO%预计值为49% vs 63%。
  • 混合效应模型显示短LTL组12个月内FVC%预计值下降-7.7%(95%CI -11.6至-3.8%,p<0.001)。
  • 短LTL组12个月内D LCO%预计值下降-4.5(95%CI -7.2至-1.8%,p=0.001)。
  • 中位随访3.6(IQR 1.8-7.0)年,无移植生存率两组相似。
  • 12个月内33例(33%)出现疾病进展,短LTL组更常见(47% vs 22%,单因素p=0.011)。

关键数值与推荐

  • 疾病进展定义为死亡、肺移植或功能呼吸下降(FVC绝对下降≥5%预计值或D LCO下降≥10%预计值)。
  • 多因素logistic回归中,较低FVC(OR 0.97,95%CI 0.94-1.00,p=0.031)和短LTL(OR 2.80,95%CI 0.99-8.29,p=0.056)为12个月进展的预测因素。

临床怎么用

  • 对RA-ILD患者,检测LTL可能有助于识别基线肺功能更差、短期进展风险更高的人群。
  • 短LTL患者可能需要更密切的肺功能监测,但尚缺乏干预性研究证据。

局限性

  • 短LTL与12个月进展的多因素关联未达统计学显著(p=0.056)。
  • 研究为观察性设计,样本量101例,结论需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Shorter leukocyte telomere length (LTL) has been reported in patients with rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) and linked to increased disease severity and mortality in idiopathic pulmonary fibrosis, which shares similarities with RA-ILD. We aimed to evaluate the impact of short LTL on baseline respiratory disease severity, disease progression and survival in patients with RA-ILD. METHODS: Patients diagnosed with RA-ILD following multidisciplinary assessment were enrolled in a prospective French observational study. LTL was measured at enrolment using qPCR. Short LTL was defined as age-adjusted LTL <10th percentile. Lung disease progression was defined as death, lung transplantation or functional respiratory decline (absolute decrease in forced vital capacity (FVC) ≥5% predicted or diffusing capacity of the lung for carbon monoxide (D LCO) ≥10% predicted). RESULTS: Among 101 patients with RA-ILD, 46% were male, mean±sd age at enrolment was 66±10 years and 43 (43%) had short LTL. Patients with short LTL had lower FVC % predicted (82% versus 93%) and D LCO % predicted (49% versus 63%) at enrolment, and greater 12-month decline in FVC % predicted and D LCO % predicted in mixed effects models (-7.7% (95% CI -11.6- -3.8%); p<0.001 and -4.5 (95% CI -7.2- -1.8%); p=0.001, respectively), although transplant-free survival was similar over a median (interquartile range) follow-up of 3.6 (1.8-7.0) years. Lung disease progression was observed within 12 months of enrolment in 33 (33%) patients, more frequently in patients with short LTL (47% versus 22%; univariate p=0.011) and lower FVC at enrolment. Multivariate logistic regression identified lower FVC and short LTL as predictors of 12-month progression (OR 0.97 (95% CI 0.94-1.00); p=0.031 and OR 2.80 (95% CI 0.99-8.29); p=0.056, respectively). CONCLUSION: Short LTL is associated with baseline severity and 12-month progression in RA-ILD.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. El Husseini K, Lee JS, Juge PA, et al. Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2025. PMID: 40967766. doi:10.1183/13993003.00587-2025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。